Trial Profile
Evaluation of Long Term Safety of Tesofensine in Patients With Obesity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Aug 2017
Price :
$35
*
At a glance
- Drugs Tesofensine (Primary)
- Indications Obesity
- Focus Adverse reactions
- Acronyms TIPO-1 Extension; TIPO-4
- Sponsors NeuroSearch
- 25 Feb 2016 New trial record